Takayuki Maruyama

7.9k total citations · 1 hit paper
171 papers, 6.4k citations indexed

About

Takayuki Maruyama is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, Takayuki Maruyama has authored 171 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pharmacology, 43 papers in Molecular Biology and 31 papers in Physiology. Recurrent topics in Takayuki Maruyama's work include Inflammatory mediators and NSAID effects (76 papers), Eicosanoids and Hypertension Pharmacology (24 papers) and Estrogen and related hormone effects (24 papers). Takayuki Maruyama is often cited by papers focused on Inflammatory mediators and NSAID effects (76 papers), Eicosanoids and Hypertension Pharmacology (24 papers) and Estrogen and related hormone effects (24 papers). Takayuki Maruyama collaborates with scholars based in Japan, United States and United Kingdom. Takayuki Maruyama's co-authors include Shuh Narumiya, Katsuhiko Mikoshiba, Toshiya Kanaji, Tomio Kanno, Shinji Nakade, Yukihiko Sugimoto, Daisuke Ekuni, Takaaki Tomofuji, Shuichi Ohuchida and Manabu Morita and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Takayuki Maruyama

168 papers receiving 6.3k citations

Hit Papers

2APB, 2-Aminoethoxydiphen... 1997 2026 2006 2016 1997 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takayuki Maruyama Japan 41 2.3k 2.2k 898 853 745 171 6.4k
Hajime Sano Japan 46 2.9k 1.2× 2.5k 1.1× 1.3k 1.5× 702 0.8× 1.3k 1.7× 242 8.4k
Osamu Hori Japan 47 4.6k 1.9× 416 0.2× 600 0.7× 1.8k 2.1× 677 0.9× 111 11.5k
Christina Piperi Greece 51 2.8k 1.2× 415 0.2× 433 0.5× 979 1.1× 829 1.1× 257 8.4k
Tatsunori Murata Japan 33 1.6k 0.7× 2.2k 1.0× 939 1.0× 1.4k 1.6× 356 0.5× 119 6.7k
Wendy B. Bollag United States 51 4.2k 1.8× 386 0.2× 806 0.9× 858 1.0× 486 0.7× 287 8.7k
Wan‐Wan Lin Taiwan 53 5.0k 2.1× 986 0.5× 387 0.4× 995 1.2× 1.6k 2.1× 211 10.7k
Sabine Steffens Germany 48 2.3k 1.0× 1.5k 0.7× 399 0.4× 617 0.7× 621 0.8× 106 7.6k
Yuqing Huo United States 50 3.7k 1.6× 453 0.2× 598 0.7× 985 1.2× 1.6k 2.1× 146 10.9k
Mark S. Kindy United States 60 5.3k 2.3× 792 0.4× 793 0.9× 3.5k 4.2× 940 1.3× 206 12.2k

Countries citing papers authored by Takayuki Maruyama

Since Specialization
Citations

This map shows the geographic impact of Takayuki Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayuki Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayuki Maruyama more than expected).

Fields of papers citing papers by Takayuki Maruyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayuki Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayuki Maruyama. The network helps show where Takayuki Maruyama may publish in the future.

Co-authorship network of co-authors of Takayuki Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Takayuki Maruyama. A scholar is included among the top collaborators of Takayuki Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takayuki Maruyama. Takayuki Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Maruyama, Takayuki, et al.. (2024). Relationship among cancer treatment, quality of life, and oral function in head and neck cancer survivors: A cross-sectional study. Supportive Care in Cancer. 32(12). 809–809. 2 indexed citations
3.
Yoneda, Toshiki, Takaaki Tomofuji, Daisuke Ekuni, et al.. (2019). Serum microRNAs and chronic periodontitis: A case-control study. Archives of Oral Biology. 101. 57–63. 30 indexed citations
4.
Mizuno, Hirofumi, Daisuke Ekuni, Takayuki Maruyama, et al.. (2017). The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: A randomized clinical trial. PLoS ONE. 12(11). e0188171–e0188171. 47 indexed citations
5.
Carlson, Noel G., Linda Schmidt, Thomas P. Huecksteadt, et al.. (2015). The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death. Journal of Neuroinflammation. 12(1). 101–101. 9 indexed citations
6.
Natura, Gabriel, Karl‐Jürgen Bär, Annett Eitner, et al.. (2013). Neuronal prostaglandin E 2 receptor subtype EP3 mediates antinociception during inflammation. Proceedings of the National Academy of Sciences. 110(33). 13648–13653. 48 indexed citations
7.
Maruyama, Takayuki, et al.. (2013). Case Report of Oral Care for the Head and Neck Cancer Patients. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology). 55(3). 262–268.
8.
Tomofuji, Takaaki, Daisuke Ekuni, Toshihiro Sanbe, et al.. (2009). Effects of improvement in periodontal inflammation by toothbrushing on serum lipopolysaccharide concentration and liver injury in rats. Acta Odontologica Scandinavica. 67(4). 200–205. 20 indexed citations
9.
Wang, Xiaojun, Yoshiharu Momota, Haruko Yanase, et al.. (2008). Urothelium EP1 receptor facilitates the micturition reflex in mice. Biomedical Research. 29(2). 105–111. 32 indexed citations
10.
Aoyama, Tomoki, Moritoshi Furu, Yongri Jin, et al.. (2008). PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage. Osteoarthritis and Cartilage. 17(4). 529–538. 31 indexed citations
11.
Ito, Masako, Keiji Nakayama, Akira Konaka, et al.. (2006). Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats. Bone. 39(3). 453–459. 33 indexed citations
12.
Tober, Kathleen L., Traci A. Wilgus, Donna F. Kusewitt, et al.. (2005). Importance of the EP1 Receptor in Cutaneous UVB-Induced Inflammation and Tumor Development. Journal of Investigative Dermatology. 126(1). 205–211. 75 indexed citations
13.
Miyake, Kiyoshi, et al.. (2003). Study on Phosphorus Removal in Water by Using Charcoal Made from Waste Materials.. Journal of Japan Society on Water Environment. 26(1). 47–52. 1 indexed citations
14.
Kitamura, Tomohiro, Masaki Itoh, Tetsuo Noda, et al.. (2003). Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Science. 94(7). 618–621. 42 indexed citations
15.
Maruyama, Toru, Toru Maruyama, Masaki Asada, et al.. (2002). Design and synthesis of a selective EP4-Receptor agonist. Part 1: discovery of 3,7-DithiaPGE1 derivatives and identification of Their ω chains. Bioorganic & Medicinal Chemistry. 10(4). 975–988. 4 indexed citations
16.
Yoshida, Keiji, Hiroji Oida, Takuya Kobayashi, et al.. (2002). Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proceedings of the National Academy of Sciences. 99(7). 4580–4585. 273 indexed citations
17.
Maruyama, Toru, Toru Maruyama, Shin‐itsu Kuwabe, et al.. (2002). Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist. Bioorganic & Medicinal Chemistry. 10(7). 2103–2110. 21 indexed citations
18.
Kawamori, Toshihiko, Seiichi Nakatsugi, Kouji Watanabe, et al.. (2001). Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development. Carcinogenesis. 22(12). 2001–2004. 76 indexed citations
19.
Sugimoto, Yukihiko, Eri Segi‐Nishida, Masato Katsuyama, et al.. (2001). The Expression of Prostaglandin E Receptors EP2 and EP4 and Their Different Regulation by Lipopolysaccharide in C3H/HeN Peritoneal Macrophages. The Journal of Immunology. 166(7). 4689–4696. 112 indexed citations
20.
Maruyama, Toru, Masaki Asada, Tai Shiraishi, et al.. (2001). Design and synthesis of a highly selective EP4-receptor agonist. part 1: 3,7-dithiaPG derivatives with high selectivity. Bioorganic & Medicinal Chemistry Letters. 11(15). 2029–2031. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026